Moody's Investors Service affirmed the "Baa2" rating on Chattanooga, Tenn.-based Erlanger Health System's $186 million of outstanding debt.
The rating affirmation is based on a number of factors, including Erlanger's strong volume and revenue growth.
The outlook is positive, reflecting Moody's Investors Service's belief that Erlanger's favorable revenue trajectory will translate into improved cash flow and liquidity.